ArticleTherapeutic advances in medical oncology2023

CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

Qiwen Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.